R&D Systems™ Recombinant Human BTN1A1/Butyrophilin Protein

Catalog No.	Quantity
84-67B-T050	50 μg

Catalog No. 84-67B-T050 Supplier R&D Systems™ Supplier No. 8467BT050

Description

Learn More About B7-related Butryophilins as Immune Modulators View Webinar

Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 0.5-2.5 μg/mL.

Specifications

• Accession Number: Q4VAN1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 696
• Molecular Weight (g/mol): M.W. (Observed): 33-41 kDa, reducing conditions; M.W. (theoretical): 25 kDa
• Name: BTN1A1/Butyrophilin
• Preparation Method: Reconstitute at 100μg/mL in PBS.
• Quality Control Testing: SDS-PAGE: 33-41kDa, reducing conditions
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human BTN1A1/Butyrophilin protein Ala27-Arg242 with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Ala27
• Without Additives: Carrier Protein
• Structural Form: Noncovalent dimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: BTN1A1
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE with silver staining.
• Protein: BTN1A1/Butyrophilin